Metabolix Announces Formation of Scientific Advisory Board for Yield10 Bioscience
"We have formed the
"Early in 2015, we presented research results demonstrating significant increases in biomass yield in switchgrass, a model system for sugarcane and corn, and in late 2015 we presented data on significant increases in oil content and seed yield in Camelina. These developments are based on enhancing photosynthesis and carbon capture
efficiency," said
"My research team has collaborated with the Yield10 team at
Background on
Danny Schnell , Ph.D. - Currently Professor and Chair of theDepartment of Plant Biology atMichigan State University , Dr. Schnell's recent research has focused on the function and regulation of protein import into chloroplasts. In addition, his laboratory team has expanded research efforts to address the critical need for crop improvement. During a collaborative project withMetabolix ,Dr. Schnell and his team discovered the breakthrough seed yield gene trait C3003.Dr. Schnell was previously in the department of biochemistry and molecular biology at UMass-Amherst where he was director of the Plant Biology Graduate Program and Head of theDepartment of Biochemistry .Dr. Schnell was also founder and co-director ofThe Institute for Massachusetts Biofuels Research .Dr. Schnell received a B.S. with honors in Life Sciences from theUniversity of Nebraska and a Ph.D. in Biochemistry and Biophysics at theUniversity of California, Davis .
Michael Lassner , Ph.D. -Dr. Lassner has more than 30 years of commercial research and development experience in agricultural biotechnology. From 2004 to 2014,Dr. Lassner held research leadership positions atDupont Pioneer . As vice president of trait discovery, he led research efforts for discovery and early development of traits including insect control, herbicide tolerance, grain quality improvement, drought tolerance and yield improvement. Prior to that,Dr. Lassner was vice president of research at Maxygen and Verdia (its agriculture spinout) to exploit their DNA shuffling platform for crop improvement.Dr. Lassner began his career at Calgene, in research focused on developing traits to improve the quality of canola oil, and at Monsanto where he led a program to develop and apply genomic technologies to improve grain quality.Dr. Lassner received a B.S. in Plant Science and a Ph.D. in Genetics from theUniversity of California, Davis .
According to the
To access an overview of Yield10 Bioscience, please visit http://www.metabolix.com/Products/Yield10-Bioscience.
About
For more information, please visit www.metabolix.com. (MBLX-G)
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements
in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding expectations for successfully deploying the Yield10 technology to achieve step changes in crop yield and transferring the technology to agriculturally significant crops, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in
Metabolix Contact:Source:Lynne H. Brum , 617-682-4693, LBrum@metabolix.com Media Inquiries: MSLGROUP Boston Amanda Fountain 781-684-0770, metabolix@mslgroup.com
News Provided by Acquire Media